(Reuters) - The fine resolves a two-count criminal charge filed by the department in federal court, which alleges that Bristol-Myers illegally concealed a patent settlement deal it had reached with Canadian drug maker Apotex Inc.
The patent settlement at issue would have delayed generic competition to Plavix, but it collapsed.
Read more at Reuters.com Government Filings News
The patent settlement at issue would have delayed generic competition to Plavix, but it collapsed.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment